Lumefantrine is an antimalarial drug used in combination with artemether to treat uncomplicated Plasmodium falciparum malaria. It interferes with parasite metabolism of hemoglobin, leading to toxic buildup. The combination therapy (ACT) is highly effective and recommended by WHO. Lumefantrine has a long half-life that supports once-daily dosing.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Lumefantrine and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Lumefantrine impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Lumefantrine-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
